Syndromic testing webinars
icon-infectious-disease-testing
Syndromic testing

Get the latest insights with syndromic testing webinars

Syndromic testing with the QIAstat-Dx system allows you to rapidly and simultaneously survey a large number of pathogens in a single sample. This means you can get comprehensive diagnostic answers in around an hour. And patients can get the right treatment faster.

To learn more about the benefits of QIAstat-Dx syndromic testing and hear about the latest insights on molecular diagnostics for infectious disease, watch our most recent webinars.

  • Learn how rapid multiplex panel tests can improve the diagnosis of gastroenteritis

    Title: Improved diagnosis of gastrointestinal infections with a rapid PCR panel test
    Speaker: Pierre Lureau Ph.D. Medical Director, Medical Biology Laboratory, Hospital Center of Niort, France

     

    Acute gastrointestinal (GI) infections are strikingly common. Worldwide, there are over 2 billion cases every year. Correctly diagnosing these infections can help healthcare providers deliver timely and efficient care. In this webinar, Pierre Lureau Ph.D., director of the Medical Biology Laboratory at the Hospital Center of Niort in Deux-Sèvres, France, explains how the QIAstat-Dx Gastrointestinal Panel has improved GI diagnostics at his institution. He describes how the panel has simplified the laboratory’s GI testing workflow, increased the detection of pathogens and improved medical services for in and outpatients.

    Learn how rapid multiplex panel tests can improve the diagnosis of gastroenteritis
  • Learn how syndromic panels can support the rapid diagnosis of critically ill patients

    Syndromic panels for quick and effective diagnosis of meningitis and gastroenteritis
    Speaker:Liliana Gabrielli, M.D., Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy

     

    When a patient is critically ill, a quick diagnosis is crucial. New multiplex molecular tools have the potential to speed up the timely and effective delivery of therapeutics. But how do these sensitive and specific multiplex tools compare to routine diagnostic approaches, like singleplex real-time PCR? In this webinar, Dr. Liliana Gabrielli evaluates the potential performance of rapid molecular syndromic testing for the etiological diagnosis of central nervous system and gastrointestinal infections.

    Learn how syndromic panels can support the rapid diagnosis of critically ill patients
  • Learn how a hospital lab validated our new multiplex panel test for meningitis/encephalitis

    Title: Quickly diagnosing meningitis/encephalitis: Clinical validation of a rapid multiplex PCR panel test
    Speaker: Thomas Sundelin Ph.D. Clinical Microbiology Department, Herlev Hospital, Denmark

     

    Infections of the central nervous system (CNS) – meningitis and encephalitis – require immediate medical attention. Recent publications indicate that incorporating rapid multiplex PCR panel testing can speed up the time-to-diagnosis for CNS infections. In this webinar, Dr. Thomas Sundelin from the Clinical Microbiology Department at Herlev Hospital in Denmark discusses the clinical validation of QIAGEN’s rapid multiplex PCR test for CNS infections, the QIAstat-Dx Meningitis/Encephalitis Panel.

    Sundelin webinar
  • Learn what experts predict for future influenza-like illness seasons in a post-COVID-19 world

    Title: Looking in the crystal ball: What will influenza-like illness season potentially look like post-COVID-19
    pandemic?
    Speaker: Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA

     

    The COVID-19 pandemic has dramatically changed the way influenza-like illnesses are diagnosed and managed. In addition, the seasonality of respiratory pathogens has shifted, making it difficult to predict future respiratory seasons. In this webinar, Dr. Roy F. Chemaly of MD Anderson Cancer Center discusses the impact of the pandemic on the incidence of respiratory viruses. He also explains how the diagnostic tools used to detect these viruses has evolved, and why a comprehensive diagnostic approach is crucial going forward, especially for immunocompromised patients.

    Chemaly webinar
  • Learn how clinicians and laboratorians are working together to implement syndromic testing

    Title: How is syndromic testing currently being used in the clinic and how will it impact diagnostics going forward?

    Panel host: Davide Manissero, MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN

    Panel members: Stephan Gehring, Prof Dr Med, Children’s Hospital Universitätsmedizin Mainz, Germany Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA Susan A. Weaver, PhD, CLS, Natividad Medical Center, USA

     

    As SARS-CoV-2 approaches endemic status, it will become increasingly important to quickly distinguish COVID-19 from other influenza-like illnesses. Multiplex PCR panel tests can detect and differentiate multiple pathogens at once. But how are these tests currently being used in the clinic and how will they impact diagnostics going forward? In this panel discussion, join three experts in infectious diseases as they discuss their personal experiences using multiplex testing and address pressing questions about this diagnostic approach.

    Panel discussion webinar
  • Learn about the clinical outcomes of using dry swabs for respiratory syndromic testing

    Title: The clinical outcomes of using dry swabs for respiratory syndromic testing 
    Speaker: Donia Bouzid, MD, PhD, Bichat Claude-Bernard Hospital, Emergency Department, France

     

    This webinar discusses how multiplex syndromic testing using dry swab samples has positively impacted clinical decision making in a hospital in Paris, France. Dr. Donia Bouzid describes how prior to adopting multiplex PCR, Bichat Claude-Bernard Hospital experienced long wait times between the arrival of patients at the hospital and the diagnosis of respiratory infections. She then discusses how the faster turnaround time and comprehensive results provided by syndromic testing with the QIAstat-Dx Analyzer have influenced clinical outcomes at the hospital, including positively impacting single room assignment.

    QIAstat-Dx, QIAstat, syndromic testing, nCoV, coronavirus, COVID-19, swab, nasal swab
  • Learn about the role of multiplex testing in the COVID-19 pandemic

    Title: Tackling COVID-19 through syndromic testing – QIAstat-Dx Respiratory SARS-CoV-2
    Speaker: Davide Manissero, MD, MRCPCH, MSc, DTM&H, VP Head of Medical Affairs & Chief Medical Officer, Infection & Immune Diagnostics, QIAGEN

     

    During this webinar, QIAGEN Chief Medical Officer Dr. Davide Manissero will discuss the role of multiplex respiratory PCR testing in the ongoing COVID-19 pandemic and how QIAGEN ramped up development efforts to be the first syndromic solution on the market. The importance of time to diagnosis and potential for co-infections as we approach the 2020-2021 influenza season will be discussed.

    Davide Manissero, VP Head of Medical Affairs, IDx France, MDx Medical Affairs, QIAGEN
  • Learn about the benefits of syndromic testing for acute respiratory illness

    Title: A new multiplex syndromic system for respiratory diagnosis and improved patient care
    Speaker: Dr. Steve Young, Director of Research and Clinical Trials, TriCore Reference Laboratories

     

    This webinar discusses how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections. Acute respiratory tract infections are caused by a wide range of viral and bacterial pathogens and may share similar clinical presentations that make it difficult for physicians to diagnose based on symptoms alone. Syndromic testing with multiplex molecular panels offers clinical labs a way to quickly distinguish between a broad array of respiratory pathogens. In this webinar, Dr. Steve Young of Tricore Reference Laboratories presents a new technology for multiplexed respiratory testing in acutely ill patients. He shares data demonstrating the capabilities of syndromic respiratory testing as well as his impressions on the ease of doing comprehensive syndromic testing using the QIAstat-Dx Analyzer.

    Syndromic testing for respiratory infections
  • Learn how rapid multiplex panel tests can improve the diagnosis of gastroenteritis
    Learn how rapid multiplex panel tests can improve the diagnosis of gastroenteritis
  • Learn how syndromic panels can support the rapid diagnosis of critically ill patients
    Learn how syndromic panels can support the rapid diagnosis of critically ill patients
  • Sundelin webinar
    Learn how a hospital lab validated our new multiplex panel test for meningitis/encephalitis
  • Chemaly webinar
    Learn what experts predict for future influenza-like illness seasons in a post-COVID-19 world
  • Panel discussion webinar
    Learn how clinicians and laboratorians are working together to implement syndromic testing
  • QIAstat-Dx, QIAstat, syndromic testing, nCoV, coronavirus, COVID-19, swab, nasal swab
    Learn about the clinical outcomes of using dry swabs for respiratory syndromic testing
  • Davide Manissero, VP Head of Medical Affairs, IDx France, MDx Medical Affairs, QIAGEN
    Learn about the role of multiplex testing in the COVID-19 pandemic
  • Syndromic testing for respiratory infections
    Learn about the benefits of syndromic testing for acute respiratory illness

The QIAstat-Dx Analyzer and QIAstat-Dx Respiratory SARS-CoV-2 Panel are intended for in vitro diagnostic use.

Product availability and claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.